Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Syndax Pharmaceuticals Inc., 3 years.
Syndax Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 29, 2026 | Syndax Pharmaceuticals Inc. | Option exercise | +8,000 | $11.81 | $94,480 |
| Oct 29, 2026 | Syndax Pharmaceuticals Inc. | Open-market sale | −8,000 | $14.21 | $113,716 |
| Feb 4, 2026 | Syndax Pharmaceuticals Inc. | Grant or award | +48,000 | — | — |
| Aug 18, 2025 | Syndax Pharmaceuticals Inc. | Option exercise | +19,200 | $7.20 | $138,240 |
| Aug 18, 2025 | Syndax Pharmaceuticals Inc. | Open-market sale | −19,200 | $15.84 | $304,128 |
| Aug 15, 2025 | Syndax Pharmaceuticals Inc. | Option exercise | +19,200 | $7.20 | $138,240 |
| Aug 15, 2025 | Syndax Pharmaceuticals Inc. | Open-market sale | −19,200 | $15.54 | $298,368 |
| Aug 14, 2025 | Syndax Pharmaceuticals Inc. | Option exercise | +19,200 | $7.20 | $138,240 |
| Aug 14, 2025 | Syndax Pharmaceuticals Inc. | Open-market sale | −19,200 | $14.19 | $272,448 |
| Feb 5, 2025 | Syndax Pharmaceuticals Inc. | Grant or award | +50,000 | — | — |
| Feb 7, 2024 | Syndax Pharmaceuticals Inc. | Grant or award | +34,000 | — | — |
| Feb 2, 2023 | Syndax Pharmaceuticals Inc. | Grant or award | +32,000 | — | — |
Questions about Dennis Podlesak
What boards is Dennis Podlesak on?
Dennis Podlesak sits on the board of Syndax Pharmaceuticals Inc.
How long has Dennis Podlesak served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.